NCT01052987
Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia treatment 2 completed NCT01519687
Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout treatment 2 unknown_status NCT00978653
The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure screening Not Available completed NCT03927677
The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. treatment 1 completed NCT01038947
Safety and Efficacy Study of Intramuscular Uricase-PEG 20 treatment 1 unknown_status NCT04801745
Vegan Diet, Amla Fruits and Uric Acid No drug interventions treatment Not Available recruiting NCT02837198
Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) basic_science 2 completed NCT02282683
Long-term Prednisone Use for End-stage Heart Failure treatment 2 / 3 unknown_status NCT05168683
Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets other 1 completed NCT03899883
Uric Acid Lowering Trial in Youth Onset T2D treatment 2 recruiting NCT06463561
CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea No drug interventions treatment 4 recruiting NCT02338128
The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients No drug interventions Not Available Not Available completed NCT03185793
Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia treatment 2 completed NCT05586971
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients treatment 3 recruiting NCT02956278
The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics basic_science 4 completed NCT03691688
The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Diseaseļ¼AURORAļ¼ Not Available Not Available unknown_status NCT06084585
The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia No drug interventions supportive_care Not Available recruiting NCT04399915
Effect of Oxalate and Urate Metabolism on CKD Evolution No drug interventions Not Available Not Available recruiting NCT03534037
Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction treatment 4 unknown_status NCT00607152
Rasburicase (Fasturtec) Registration Trial treatment 3 terminated NCT00997542
Allopurinol in Chronic Heart Failure treatment 4 completed NCT04987242
An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) treatment 2 completed NCT03495999
Hyperuricemia and Left Ventricular Diastolic Function No drug interventions Not Available Not Available terminated NCT03934099
A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia treatment 2 completed NCT03906006
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects No drug interventions treatment 1 completed NCT05226013
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers treatment 1 unknown_status NCT00422318
Treatment of Hyperuricemia in Patients With Heart Failure treatment 4 completed NCT04236219
ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers treatment 1 completed NCT00230217
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy prevention 4 completed NCT05434858
Imagery as Biomarker of Gout No drug interventions prevention Not Available recruiting NCT02190786
Phase II Exploratory Clinical Study of KUX-1151 No drug interventions Not Available 2 completed NCT01336686
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout treatment 2 completed NCT05119686
Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients No drug interventions treatment 2 completed NCT01532622
Impact of Blueberries on Uric Acid and Quality of Life No drug interventions treatment Not Available completed NCT01830725
Purine Metabolism Enzyme SNP to Uric Acid Production No drug interventions Not Available Not Available completed NCT02502565
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia No drug interventions Not Available Not Available unknown_status NCT01407874
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency treatment 2 completed NCT02891031
The Effects of Rhus Coriaria L. on Serum Uric Acid Levels No drug interventions treatment Not Available unknown_status NCT00868673
The Role Of Fructose and Uric Acid In the Development of Obesity and Metabolic Syndrome No drug interventions screening Not Available completed NCT05474560
Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients treatment 4 completed NCT04987294
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease treatment 2 terminated NCT02213562
Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia No drug interventions prevention Not Available completed NCT02600780
Zurig (Febuxostat) 40mg Efficacy and Safety Trial treatment 4 completed NCT03636529
Tart Cherry Juice and Markers of Inflammation, CVD, and Diabetes No drug interventions treatment Not Available completed NCT04463940
Xanthine Oxidase and Uric Acid Origin in Preeclamptic Women No drug interventions Not Available Not Available unknown_status NCT04161872
Nutraceutical on Hyperuricemia No drug interventions treatment 4 completed NCT02008968
Effect of Allopurinol Treatment on Insulin Resistance prevention Not Available unknown_status NCT05954169
Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects treatment 1 completed NCT01363869
Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals No drug interventions treatment Not Available completed NCT04070846
Mass Balance Study of [14C]LC350189 in Healthy Volunteers treatment 1 completed NCT04066712
Renal PK Study of LC350189 treatment 1 completed NCT05913310
Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia No drug interventions treatment 4 not_yet_recruiting NCT02944214
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients treatment Not Available unknown_status NCT04886050
Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults treatment 1 completed NCT03425708
Effect of Hyperuricaemia on Chronic Renal Disease treatment 4 unknown_status NCT04586803
Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers basic_science 1 unknown_status NCT03211403
Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level other 1 completed NCT02462421
Pharmacogenetics of SGLT2 Inhibitors basic_science 4 terminated NCT06439602
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients No drug interventions treatment 3 recruiting NCT06119802
Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation No drug interventions Not Available Not Available recruiting NCT04953533
Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout No drug interventions Not Available Not Available unknown_status NCT05253833
Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout treatment 2 active_not_recruiting NCT00174954
Magnetic Resonance Imaging in Subjects With Gouty Tophi No drug interventions Not Available Not Available completed NCT03473951
The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic Syndrome No drug interventions Not Available Not Available unknown_status NCT04352153
Role of Uralyt-U in Patients With Hyperuricemia treatment Not Available unknown_status NCT00302653
Rasburicase in Tumor Lysis Syndrome treatment 4 completed NCT01818505
The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome No drug interventions Not Available Not Available unknown_status NCT05504083
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients treatment 2 recruiting NCT04072471
Post-Authorisation Safety Study of Lesinurad Not Available Not Available withdrawn NCT00563771
Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome treatment 4 completed NCT00230178
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome prevention 3 completed NCT04144088
Traditional Chinese Medicine in the Treatment of Patients With Hyperuricemia. No drug interventions basic_science 2 completed NCT03865407
Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease treatment 2 terminated NCT03218709
The Intervention of Multi-vitamin With Minerals to Hyperuricemia treatment 4 unknown_status NCT04157959
The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia treatment 1 unknown_status NCT00921375
Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia No drug interventions prevention 3 completed NCT06056570
Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia treatment 1 / 2 recruiting NCT00741442
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout treatment 2 completed NCT04165499
Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid. No drug interventions treatment 0 completed NCT01984749
Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy treatment Not Available unknown_status NCT03921736
Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women. treatment 4 completed NCT05574036
Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia treatment 2 recruiting NCT00995618
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia treatment 2 completed NCT02959918
Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid treatment 2 completed NCT01881919
Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial No drug interventions basic_science 0 completed NCT01021241
Safety and Efficacy Study of Intravenous Uricase-PEG 20 treatment 1 unknown_status NCT06501534
A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects treatment 2 not_yet_recruiting NCT04139824
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults treatment 1 completed NCT04622124
A Safety and Tolerability Study of FCN-207 in Healthy Volunteers No drug interventions treatment 1 completed NCT04938024
Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C) No drug interventions treatment Not Available completed NCT04040816
Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients No drug interventions treatment 2 completed NCT03648996
Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid treatment 2 completed NCT05586958
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients treatment 3 recruiting NCT00288158
Primary Prevention of Hypertension in Obese Adolescents treatment 2 completed NCT02252835
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout treatment 2 completed NCT04829435
Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) treatment 1 completed NCT03149939
Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients treatment Not Available completed NCT03118739
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria treatment 2 completed NCT04199325
Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial treatment Not Available recruiting NCT04799925
Hyperuricemia and Diabetic Nephropathy Not Available Not Available unknown_status NCT04966325
Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects treatment 0 completed NCT02557126
Study of URC102 to Assess the Safety and Efficacy in Gout Patients No drug interventions treatment 2 completed NCT03569020
The Diet Gout Trial No drug interventions treatment Not Available completed NCT04180982
A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia treatment 2 unknown_status NCT04060173
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 No drug interventions treatment 1 completed NCT05476627
Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases No drug interventions Not Available Not Available recruiting NCT01931527
Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status other Not Available completed NCT04012294
Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms treatment 3 unknown_status NCT02344862
Study of FYU-981 in Hyperuricemia With or Without Gout treatment 2 completed NCT06168929
Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects treatment 1 completed NCT03473444
Prevalence of Hyperuricemia in Pakistan No drug interventions Not Available Not Available unknown_status NCT00664144
Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma treatment 2 terminated NCT00186940
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients Not Available Not Available completed NCT06310967
A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease No drug interventions treatment 1 / 2 not_yet_recruiting NCT02416167
Study of FYU-981 in Hyperuricemia With or Without Gout treatment 2 completed NCT06189404
Effect of Tigulixostat on the Pharmacokinetics of Theophylline basic_science 1 completed NCT06315569
The Effect of Exercise at Different Time Intervals on Hyperuricemia No drug interventions prevention Not Available recruiting NCT01361646
Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 treatment 1 completed NCT02290210
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients No drug interventions treatment 2 completed NCT03200210
Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients treatment 4 unknown_status NCT00955981
Gout Dose Response Study treatment 2 completed NCT02338323
Compare the Renal Protective Effects of Febuxostat and Benzbromarone treatment Not Available completed NCT04638543
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia No drug interventions treatment 2 completed NCT06315543
Effect of Increased Daily Water Intake in Patients With Hyperuricemia No drug interventions treatment Not Available recruiting NCT00919243
Prednisone for Heart Failure Patients With Hyperuricemia treatment 4 completed NCT05245890
Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals No drug interventions Not Available Not Available unknown_status NCT01265264
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol treatment 2 completed NCT00756964
Lowering Serum Uric Acid to Prevent Acute Kidney Injury prevention 2 completed NCT01109121
Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) treatment 2 completed NCT01416402
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients treatment 2 completed NCT03076684
Gender Differences in the Metabolic Effects of Uric Acid basic_science 0 withdrawn NCT04733079
Treat-to-target by Email During Urate-lowering Therapy in Gout No drug interventions treatment Not Available recruiting NCT00631579
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma treatment 2 completed